Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Krudys

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|November 10, 2018
Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future PerspectivesScott Marshall, Rajanikanth Madabushi, Efthymios Manolis, et al.
Clinical Pharmacokinetics|June 22, 2005
Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studiesEvan D Kharasch, Dale Whittington, Christine Hoffer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2026
Advancing Theranostics in Alzheimer Disease: FDA Approval of Amyloid-β PET Drugs for Selection of Patients for Amyloid-β-Directed Therapies and Other Labeling UpdatesHayoung Koo, Venkata Mattay, A Alex Hofling, et al.
Journal of Clinical Pharmacology|August 9, 2024
Driving Efficiency: Leveraging Model-Informed Approaches in 505(b)(2) Regulatory ActionsVishnu Dutt Sharma, Venkatesh Atul Bhattaram, Kevin Krudys, et al.
Expert Review of Clinical Pharmacology|November 25, 2011
Knowledge management for efficient quantitative analyses during regulatory reviewsKevin Krudys, Fang Li, Jeffry Florian, et al.
Clinical Pharmacology and Therapeutics|June 9, 2022
Extrapolation of Efficacy from Adults to Pediatric Patients of Drugs for Treatment of Partial Onset Seizures: A Regulatory PerspectiveShailly Mehrotra, Atul Bhattaram, Kevin Krudys, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2016
Role of Quantitative Clinical Pharmacology in Pediatric Approval and LabelingNitin Mehrotra, Atul Bhattaram, Justin C Earp, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 31, 2013
The IQ-CSRC prospective clinical Phase 1 study: "Can early QT assessment using exposure response analysis replace the thorough QT study?"Borje Darpo, Nenad Sarapa, Christine Garnett, et al.
Journal of Clinical Pharmacology|January 23, 2020
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and VomitingJeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, et al.
Journal of Clinical Pharmacology|April 5, 2016
Exposure Matching for Extrapolation of Efficacy in Pediatric Drug DevelopmentYeruk Mulugeta, Jeffrey S Barrett, Robert Nelson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
CPT: Pharmacometrics & Systems Pharmacology|November 10, 2018
Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future PerspectivesScott Marshall, Rajanikanth Madabushi, Efthymios Manolis, et al.
Clinical Pharmacokinetics|June 22, 2005
Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studiesEvan D Kharasch, Dale Whittington, Christine Hoffer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2026
Advancing Theranostics in Alzheimer Disease: FDA Approval of Amyloid-β PET Drugs for Selection of Patients for Amyloid-β-Directed Therapies and Other Labeling UpdatesHayoung Koo, Venkata Mattay, A Alex Hofling, et al.
Journal of Clinical Pharmacology|August 9, 2024
Driving Efficiency: Leveraging Model-Informed Approaches in 505(b)(2) Regulatory ActionsVishnu Dutt Sharma, Venkatesh Atul Bhattaram, Kevin Krudys, et al.
Expert Review of Clinical Pharmacology|November 25, 2011
Knowledge management for efficient quantitative analyses during regulatory reviewsKevin Krudys, Fang Li, Jeffry Florian, et al.
Clinical Pharmacology and Therapeutics|June 9, 2022
Extrapolation of Efficacy from Adults to Pediatric Patients of Drugs for Treatment of Partial Onset Seizures: A Regulatory PerspectiveShailly Mehrotra, Atul Bhattaram, Kevin Krudys, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2016
Role of Quantitative Clinical Pharmacology in Pediatric Approval and LabelingNitin Mehrotra, Atul Bhattaram, Justin C Earp, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 31, 2013
The IQ-CSRC prospective clinical Phase 1 study: "Can early QT assessment using exposure response analysis replace the thorough QT study?"Borje Darpo, Nenad Sarapa, Christine Garnett, et al.
Journal of Clinical Pharmacology|January 23, 2020
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and VomitingJeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, et al.
Journal of Clinical Pharmacology|April 5, 2016
Exposure Matching for Extrapolation of Efficacy in Pediatric Drug DevelopmentYeruk Mulugeta, Jeffrey S Barrett, Robert Nelson, et al.
Pageof 2